Cargando…
Microneedle-based bioassays
Disease diagnosis and therapeutic efficacy can be monitored via a number of established bioassays that sample body fluids to assess and monitor health conditions. Traditional bioassays generally include several steps and start with invasive body fluid extraction procedures. These steps are painful a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419780/ https://www.ncbi.nlm.nih.gov/pubmed/36132929 http://dx.doi.org/10.1039/d0na00543f |
_version_ | 1784777256128741376 |
---|---|
author | Zhu, Jixiang Zhou, Xingwu Libanori, Alberto Sun, Wujin |
author_facet | Zhu, Jixiang Zhou, Xingwu Libanori, Alberto Sun, Wujin |
author_sort | Zhu, Jixiang |
collection | PubMed |
description | Disease diagnosis and therapeutic efficacy can be monitored via a number of established bioassays that sample body fluids to assess and monitor health conditions. Traditional bioassays generally include several steps and start with invasive body fluid extraction procedures. These steps are painful and often require specialized techniques and tailored equipment, as well as the supervision of professional medical personnel. Innovations in engineering alternative bioassays to address these shortcomings are thus desired. Microneedles (MNs) represent promising tools to sample body fluids, in view of their minimal invasiveness, painlessness, and uncomplicated implementation. Recent progress in microfabrication and materials engineering, including the development of hollow and solid MNs with uniquely optimized architectures and multi-functional materials, has positioned MN-based platforms as prime candidates for bioassay solutions. In this minireview, we summarize the studies of MN-based platforms for detection and diagnosis. We categorize the platforms based on three different mechanisms: MNs as body fluid reservoirs, MNs integrated with electrochemical assays, and MNs engineered with colorimetric analyses. A discussion of design principles for MN-based bioassay platforms is presented. We also discuss the challenges and opportunities associated with MN-based bioassays in future clinical applications. |
format | Online Article Text |
id | pubmed-9419780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | RSC |
record_format | MEDLINE/PubMed |
spelling | pubmed-94197802022-09-20 Microneedle-based bioassays Zhu, Jixiang Zhou, Xingwu Libanori, Alberto Sun, Wujin Nanoscale Adv Chemistry Disease diagnosis and therapeutic efficacy can be monitored via a number of established bioassays that sample body fluids to assess and monitor health conditions. Traditional bioassays generally include several steps and start with invasive body fluid extraction procedures. These steps are painful and often require specialized techniques and tailored equipment, as well as the supervision of professional medical personnel. Innovations in engineering alternative bioassays to address these shortcomings are thus desired. Microneedles (MNs) represent promising tools to sample body fluids, in view of their minimal invasiveness, painlessness, and uncomplicated implementation. Recent progress in microfabrication and materials engineering, including the development of hollow and solid MNs with uniquely optimized architectures and multi-functional materials, has positioned MN-based platforms as prime candidates for bioassay solutions. In this minireview, we summarize the studies of MN-based platforms for detection and diagnosis. We categorize the platforms based on three different mechanisms: MNs as body fluid reservoirs, MNs integrated with electrochemical assays, and MNs engineered with colorimetric analyses. A discussion of design principles for MN-based bioassay platforms is presented. We also discuss the challenges and opportunities associated with MN-based bioassays in future clinical applications. RSC 2020-09-18 /pmc/articles/PMC9419780/ /pubmed/36132929 http://dx.doi.org/10.1039/d0na00543f Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Chemistry Zhu, Jixiang Zhou, Xingwu Libanori, Alberto Sun, Wujin Microneedle-based bioassays |
title | Microneedle-based bioassays |
title_full | Microneedle-based bioassays |
title_fullStr | Microneedle-based bioassays |
title_full_unstemmed | Microneedle-based bioassays |
title_short | Microneedle-based bioassays |
title_sort | microneedle-based bioassays |
topic | Chemistry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419780/ https://www.ncbi.nlm.nih.gov/pubmed/36132929 http://dx.doi.org/10.1039/d0na00543f |
work_keys_str_mv | AT zhujixiang microneedlebasedbioassays AT zhouxingwu microneedlebasedbioassays AT libanorialberto microneedlebasedbioassays AT sunwujin microneedlebasedbioassays |